日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2020-09-25 | 15:20-15:30 | 淋巴瘤/310 |
淋巴瘤 14(发言8分钟+讨论2分钟) |
讲者 | Ibrutinib Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Patients With Untreated Non-Germinal Center B-Cell–Like (GCB) Diffuse Large B-Cell Lymphoma (DLBCL): a Chinese Subgroup Analysis of the Phase 3 PHOENIX Trial |